Mass Campaigns With Fractional Dose Pneumococcal Vaccines in Sub-Saharan Africa (fPCV)

PHASE4CompletedINTERVENTIONAL
Enrollment

44,618

Participants

Timeline

Start Date

December 30, 2021

Primary Completion Date

March 14, 2023

Study Completion Date

October 3, 2023

Conditions
Pneumococcal Carriage
Interventions
BIOLOGICAL

PCV10 full dose

Mass vaccination campaign with one single dose PCV10 vaccine administered as a full dose.

BIOLOGICAL

PCV10 fractional dose

Mass vaccination campaign with one single dose PCV10 vaccine administered as a fractional dose.

Trial Locations (1)

Unknown

Epicentre, Maradi

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

London School of Hygiene and Tropical Medicine

OTHER

collaborator

Kenya Medical Research Institute

OTHER

collaborator

Universite Abdou Moumouni de Niamey, Niger

OTHER

lead

Epicentre

OTHER